Canine Atopic Dermatitis Global Market Report 2025

Description

Canine atopic dermatitis is a long-term, inflammatory skin disorder in dogs triggered by allergic reactions to environmental allergens like pollen, dust mites, mold, or certain foods. It is a hereditary condition that results in severe itching, skin redness, and frequent skin infections. The main goal of treating canine atopic dermatitis is to alleviate itching, decrease inflammation, and control secondary infections to enhance the dog's overall well-being.

The primary product categories used in the management of canine atopic dermatitis include glucocorticoids, antihistamines, immunosuppressants, monoclonal antibodies (mAbs), and other related therapies. Glucocorticoids are synthetic, broad-acting hormones that effectively relieve itching and inflammation by suppressing the immune response. This condition affects a variety of dog breeds, including German Shepherds, Terriers, Retrievers, and others, with common indications such as ectoparasites, food allergies, and allergic skin infections. Treatment methods include oral, topical, and injectable routes, and these products are distributed through veterinary clinics, retail pharmacies, online pharmacies, and other distribution channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care equipment. Higher duties on imported veterinary drugs, diagnostic tools, surgical instruments, and pet care products have increased operational costs for veterinary clinics, animal hospitals, and livestock care providers, forcing them to raise service fees or absorb shrinking margins. Livestock and agricultural sectors face similar challenges, with tariffs on feed additives, vaccines, and breeding equipment driving up production costs and affecting animal health management. Additionally, retaliatory tariffs in key export markets have reduced demand for U.S.-produced veterinary products, further straining industry revenues. The sector must now prioritize local sourcing, preventive care solutions, and digital health innovations to mitigate rising costs while maintaining high standards of animal care.

The canine atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides canine atopic dermatitis market statistics, including canine atopic dermatitis industry global market size, regional shares, competitors with a canine atopic dermatitis market share, detailed canine atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the canine atopic dermatitis industry. The canine atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The canine atopic dermatitis market size has grown rapidly in recent years. It will grow from $2.49 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to a rise in pet ownership, increased awareness of pet health, a growing incidence of allergic conditions in dogs, higher spending on veterinary healthcare, and the expanding availability of pet insurance.

The canine atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $4.09 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth during the forecast period can be attributed to the increasing adoption of telemedicine in veterinary care, rising demand for personalized pet treatments, growing investments in veterinary research and development, the expanding trend of pet humanization, and the increased use of artificial intelligence in veterinary diagnostics. Key trends expected in the forecast period include advancements in monoclonal antibody therapies, the application of artificial intelligence in diagnostic tools, integration of telemedicine for dermatological care, the use of wearable devices for tracking symptoms, progress in allergen-specific immunotherapy, and the development of mobile applications for monitoring treatment.

The growing number of skin allergy cases in dogs is expected to drive the expansion of the canine atopic dermatitis market. Skin allergies in dogs occur when their immune system overreacts to allergens like pollen, certain foods, or flea bites, leading to symptoms such as itching, redness, and irritation. This increase is partly due to greater exposure to environmental pollutants and allergens, which can trigger intensified immune responses and cause skin discomfort. Treatments for canine atopic dermatitis help alleviate these issues by minimizing inflammation and itching, as well as preventing secondary infections, thereby improving dogs' skin health and comfort. For example, in January 2024, the National Institutes of Health (NIH), a US-based government agency, reported that 7,915 dog owners (28.7%) indicated their dogs had experienced skin-related conditions. The data showed a steady increase in skin issues with age, from 7% in puppies to 37% in senior dogs. This rising prevalence is contributing to the growth of the canine atopic dermatitis market.

The increase in pet ownership is also contributing to the growth of the canine atopic dermatitis market. Pet ownership involves caring for domesticated animals, such as dogs, cats, and other companions, within a household setting. A key driver of this trend is the growing humanization of pets, where animals are increasingly seen as family members and sources of emotional support and companionship. Addressing canine atopic dermatitis plays an essential role in improving pets' lives by easing chronic itching and inflammation, enhancing skin health, and boosting overall comfort and well-being. For instance, in April 2025, the American Pet Products Association (APPA), a US-based trade association, reported that 94 million US households (71%) owned a pet, up from 86.9 million households (66%) in 2023-2024. As a result, the increase in pet ownership is fueling demand in the canine atopic dermatitis market.

Leading companies in the canine atopic dermatitis market are pursuing regulatory approvals to expand the global reach and availability of their treatments. Regulatory approvals are formal authorizations granted by health authorities after verifying that medical products meet safety, efficacy, and quality standards through comprehensive testing. For example, in September 2024, Elanco Animal Health Inc., a US-based pharmaceutical company focused on animal health, received US FDA approval for Zenrelia, a once-daily oral JAK inhibitor designed to treat allergic and atopic dermatitis in dogs. Zenrelia represents a significant innovation by addressing chronic, acute, or seasonal itching and inflammation with a single daily tablet. It functions by targeting the source of the itch and blocking the signaling pathways responsible for allergic reactions, thereby breaking the itch-scratch cycle. The treatment provides noticeable improvement from the first dose and helps minimize rebound itching, which is a common drawback in dogs treated with competing JAK inhibitors.

Major players in the canine atopic dermatitis market are Merck & Co. Inc., Zoetis Inc., Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Royal Canin SAS, Ceva Sante Animale S.A., Boragen, Virbac S.A., Elanco Animal Health Inc., Dechra Pharmaceuticals PLC, Antech Diagnostics Inc., Vetoquinol S.A., Heska Corporation, Bioiberica S.A.U., Bimeda Animal Health Limited, Animal Dermatology Group Inc., Kindred Biosciences Inc., Bioceltix S.A., Nextmune AB, OKAVA Pharmaceuticals Inc.

North America was the largest region in the canine atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in canine atopic dermatitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the canine atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The canine atopic dermatitis market consists of sales of products including medicated shampoos, hypoallergenic diets, omega-3 fatty acid supplements, skin barrier repair creams, and topical antimicrobial or antifungal treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Canine Atopic Dermatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on canine atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for canine atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The canine atopic dermatitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Glucocorticoids; Antihistamines; Immunosuppressants; Monoclonal Antibodies (mAbs); Other Products
2) By Dog Breed: German Shepherd; Terriers; Retrievers; Other Dog Breeds
3) By Indication: Ectoparasites; Food Allergy; Allergic Skin Infections; Other Indications
4) By Route Of Administration: Oral; Topical; Injectable
5) By Distribution Channel: Veterinary Clinics; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Glucocorticoids: Prednisone; Prednisolone; Dexamethasone; Methylprednisolone; Hydrocortisone; Triamcinolone
2) By Antihistamines: Diphenhydramine; Hydroxyzine; Cetirizine; Loratadine; Chlorpheniramine
3) By Immunosuppressants: Cyclosporine; Tacrolimus; Azathioprine; Mycophenolate Mofetil
4) By Monoclonal Antibodies: Lokivetmab; Investigational Monoclonal Antibodies
5) By Other Products: Essential Fatty Acid Supplements; Medicated Shampoos And Sprays; Allergen-Specific Immunotherapy (ASIT); Skin Barrier Repair Creams; Nutraceuticals And Probiotics
Companies Mentioned: Merck & Co. Inc.; Zoetis Inc.; Hill's Pet Nutrition Inc.; IDEXX Laboratories Inc.; Royal Canin SAS; Ceva Sante Animale S.A.; Boragen; Virbac S.A.; Elanco Animal Health Inc.; Dechra Pharmaceuticals PLC; Antech Diagnostics Inc.; Vetoquinol S.A.; Heska Corporation; Bioiberica S.A.U.; Bimeda Animal Health Limited; Animal Dermatology Group Inc.; Kindred Biosciences Inc.; Bioceltix S.A.; Nextmune AB; OKAVA Pharmaceuticals Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r36946

1. Executive Summary

2. Canine Atopic Dermatitis Market Characteristics

3. Canine Atopic Dermatitis Market Trends And Strategies

4. Canine Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Canine Atopic Dermatitis Growth Analysis And Strategic Analysis Framework

5.1. Global Canine Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Canine Atopic Dermatitis Market Growth Rate Analysis
5.4. Global Canine Atopic Dermatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Canine Atopic Dermatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Canine Atopic Dermatitis Total Addressable Market (TAM)

6. Canine Atopic Dermatitis Market Segmentation

6.1. Global Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glucocorticoids
Antihistamines
Immunosuppressants
Monoclonal Antibodies (mAbs)
Other Products
6.2. Global Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
German Shepherd
Terriers
Retrievers
Other Dog Breeds
6.3. Global Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ectoparasites
Food Allergy
Allergic Skin Infections
Other Indications
6.4. Global Canine Atopic Dermatitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Injectable
6.5. Global Canine Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Clinics
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.6. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Prednisolone
Dexamethasone
Methylprednisolone
Hydrocortisone
Triamcinolone
6.7. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diphenhydramine
Hydroxyzine
Cetirizine
Loratadine
Chlorpheniramine
6.8. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cyclosporine
Tacrolimus
Azathioprine
Mycophenolate Mofetil
6.9. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lokivetmab
Investigational Monoclonal Antibodies
6.10. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Essential Fatty Acid Supplements
Medicated Shampoos And Sprays
Allergen-Specific Immunotherapy (ASIT)
Skin Barrier Repair Creams
Nutraceuticals And Probiotics

7. Canine Atopic Dermatitis Market Regional And Country Analysis

7.1. Global Canine Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Canine Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Canine Atopic Dermatitis Market

8.1. Asia-Pacific Canine Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Canine Atopic Dermatitis Market

9.1. China Canine Atopic Dermatitis Market Overview
9.2. China Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Canine Atopic Dermatitis Market

10.1. India Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Canine Atopic Dermatitis Market

11.1. Japan Canine Atopic Dermatitis Market Overview
11.2. Japan Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Canine Atopic Dermatitis Market

12.1. Australia Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Canine Atopic Dermatitis Market

13.1. Indonesia Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Canine Atopic Dermatitis Market

14.1. South Korea Canine Atopic Dermatitis Market Overview
14.2. South Korea Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Canine Atopic Dermatitis Market

15.1. Western Europe Canine Atopic Dermatitis Market Overview
15.2. Western Europe Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Canine Atopic Dermatitis Market

16.1. UK Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Canine Atopic Dermatitis Market

17.1. Germany Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Canine Atopic Dermatitis Market

18.1. France Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Canine Atopic Dermatitis Market

19.1. Italy Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Canine Atopic Dermatitis Market

20.1. Spain Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Canine Atopic Dermatitis Market

21.1. Eastern Europe Canine Atopic Dermatitis Market Overview
21.2. Eastern Europe Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Canine Atopic Dermatitis Market

22.1. Russia Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Canine Atopic Dermatitis Market

23.1. North America Canine Atopic Dermatitis Market Overview
23.2. North America Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Canine Atopic Dermatitis Market

24.1. USA Canine Atopic Dermatitis Market Overview
24.2. USA Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Canine Atopic Dermatitis Market

25.1. Canada Canine Atopic Dermatitis Market Overview
25.2. Canada Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Canine Atopic Dermatitis Market

26.1. South America Canine Atopic Dermatitis Market Overview
26.2. South America Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Canine Atopic Dermatitis Market

27.1. Brazil Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Canine Atopic Dermatitis Market

28.1. Middle East Canine Atopic Dermatitis Market Overview
28.2. Middle East Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Canine Atopic Dermatitis Market

29.1. Africa Canine Atopic Dermatitis Market Overview
29.2. Africa Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Canine Atopic Dermatitis Market Competitive Landscape And Company Profiles

30.1. Canine Atopic Dermatitis Market Competitive Landscape
30.2. Canine Atopic Dermatitis Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Hill's Pet Nutrition Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Royal Canin SAS Overview, Products and Services, Strategy and Financial Analysis

31. Canine Atopic Dermatitis Market Other Major And Innovative Companies

31.1. Ceva Sante Animale S.A.
31.2. Boragen
31.3. Virbac S.A.
31.4. Elanco Animal Health Inc.
31.5. Dechra Pharmaceuticals PLC
31.6. Antech Diagnostics Inc.
31.7. Vetoquinol S.A.
31.8. Heska Corporation
31.9. Bioiberica S.A.U.
31.10. Bimeda Animal Health Limited
31.11. Animal Dermatology Group Inc.
31.12. Kindred Biosciences Inc.
31.13. Bioceltix S.A.
31.14. Nextmune AB
31.15. OKAVA Pharmaceuticals Inc

32. Global Canine Atopic Dermatitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Canine Atopic Dermatitis Market

34. Recent Developments In The Canine Atopic Dermatitis Market

35. Canine Atopic Dermatitis Market High Potential Countries, Segments and Strategies

35.1 Canine Atopic Dermatitis Market In 2029 - Countries Offering Most New Opportunities
35.2 Canine Atopic Dermatitis Market In 2029 - Segments Offering Most New Opportunities
35.3 Canine Atopic Dermatitis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer